KTTA - Pasithea Therapeutics Corp
Previous close
4.7104
0 0%
Share volume: 942
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$4.71
0.00
0.00%
Fundamental analysis
14%
Profitability
6%
Dept financing
2%
Liquidity
75%
Performance
10%
Performance
5 Days
-2.12%
1 Month
-11.28%
3 Months
-22.20%
6 Months
-40.12%
1 Year
-62.75%
2 Year
-80.55%
Key data
Stock price
$4.71
DAY RANGE
N/A - N/A
52 WEEK RANGE
$4.40 - $17.40
52 WEEK CHANGE
-$0.63
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO:
Region: US
Website:
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website:
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Recent news